CLS FAST International hosts a successful two-day program with University of Edinburgh and University of Strathclyde


August 26, 2022

As a collaboration between California Life Sciences (CLS) and the Healthcare Technology Accelerator Facility (HTAF) at University of Edinburgh, the CLS team had the pleasure of hosting a delegation from the Queens Medical Research Institute at University of Edinburgh and Strathclyde University, Glasgow. We worked together on an early liver injury assay with potential applications as a rapid POC test in Emergency room settings and potential applications in clinical trials as predictive marker for liver toxicity.

CLS hosted this delegation of eight distinguished experts from both Universities for a two-day Program with selected CLS advisors to discuss application cases, POC strategy, and development strategy in the U.S.


  • Dr. Paul Fineran – Healthcare Technology Portfolio Project and Development Manager, Healthcare Technology Accelerator Facility, Univ. of Edinburgh
  • Prof. James Dear, MD – Professor of Pharmacology, Univ. of Edinburgh
  • Prof. Karen Faulds – Professor of Chemistry, Univ. of Strathclyde
  • Prof. Duncan Graham – Executive Dean, Faculty of Science, Univ. of Strathclyde
  • Dr. Sian Sloan-Dennison — Research Associate, Pure and Applied Chemistry, Univ. of Strathclyde
  • Dr. Benjamin Clark — Pure and Applied Chemistry, Univ. of Strathclyde
  • Dr. Kathleen Scullion — Post-Doc, Univ. of Edinburgh, Micro-RNA126 publication – kidney injury
  • Joanne Mair — Translational Healthcare Technologies, Project Manager, PhD program, Univ. of Edinburgh